Taking it Personally: Personalized Utilization of the Human Microbiome in Health and Disease

Cell Host and Microbe

Volumn 19, Issue 1, 2016, Pages 12-20

  Zmora, Niv ^a,b,c   Zeevi, David ^a   Korem, Tal ^a   Segal, Eran ^a   Elinav, Eran ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL DECISION MAKING; DISEASES; FOLLOW UP; HEALTH; HUMAN; INTESTINE FLORA; MICROBIOME; NONHUMAN; NUTRITION; PATIENT CARE; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; BACTERIUM; CLASSIFICATION; GASTROINTESTINAL TRACT; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PROCEDURES; TRENDS;

BACTERIA; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; PRECISION MEDICINE;

EID: 84959523025     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2015.12.016     Document Type: Review

References (87)

1. N.A. Afzal, S. Davies, M. Paintin, F. Arnaud-Battandier, J.A. Walker-Smith, S. Murch, R. Heuschkel, and J. Fell Colonic Crohn's disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved Dig. Dis. Sci. 50 2005 1471 1475
2. J. Ahn, R. Sinha, Z. Pei, C. Dominianni, J. Wu, J. Shi, J.J. Goedert, R.B. Hayes, and L. Yang Human gut microbiome and risk for colorectal cancer J. Natl. Cancer Inst. 105 2013 1907 1911
3. I.D.R. Arnott, C.J. Landers, E.J. Nimmo, H.E. Drummond, B.K.R. Smith, S.R. Targan, and J. Satsangi Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype Am. J. Gastroenterol. 99 2004 2376 2384
4. M.-C. Arrieta, L.T. Stiemsma, P.A. Dimitriu, L. Thorson, S. Russell, S. Yurist-Doutsch, B. Kuzeljevic, M.J. Gold, H.M. Britton, D.L. Lefebvre, et al. CHILD Study Investigators Early infancy microbial and metabolic alterations affect risk of childhood asthma Sci. Transl. Med. 7 2015 307ra152-307ra152
5. F. Bäckhed, H. Ding, T. Wang, L.V. Hooper, G.Y. Koh, A. Nagy, C.F. Semenkovich, and J.I. Gordon The gut microbiota as an environmental factor that regulates fat storage Proc. Natl. Acad. Sci. USA 101 2004 15718 15723
6. M. Baumgart, B. Dogan, M. Rishniw, G. Weitzman, B. Bosworth, R. Yantiss, R.H. Orsi, M. Wiedmann, P. McDonough, S.G. Kim, and et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum ISME J. 1 2007 403 418
7. H. Bisgaard, N. Li, K. Bonnelykke, B.L.K. Chawes, T. Skov, G. Paludan-Müller, J. Stokholm, B. Smith, and K.A. Krogfelt Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age J. Allergy Clin. Immunol. 128 2011 646-52.e1, 5
8. A. Biswas, V.R. Rao, S. Seth, and S.K. Maulik Next generation sequencing in cardiomyopathy: towards personalized genomics and medicine Mol. Biol. Rep. 41 2014 4881 4888
9. C.T. Brown, A.G. Davis-Richardson, A. Giongo, K.A. Gano, D.B. Crabb, N. Mukherjee, G. Casella, J.C. Drew, J. Ilonen, M. Knip, and et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes PLoS ONE 6 2011 e25792
10. R.N. Carmody, G.K. Gerber, J.M. Luevano Jr., D.M. Gatti, L. Somes, K.L. Svenson, and P.J. Turnbaugh Diet dominates host genotype in shaping the murine gut microbiota Cell Host Microbe 17 2015 72 84
11. M. Castellarin, R.L. Warren, J.D. Freeman, L. Dreolini, M. Krzywinski, J. Strauss, R. Barnes, P. Watson, E. Allen-Vercoe, R.A. Moore, and R.A. Holt Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma Genome Res. 22 2012 299 306
12. M.J. Claesson, I.B. Jeffery, S. Conde, S.E. Power, E.M. O'Connor, S. Cusack, H.M.B. Harris, M. Coakley, B. Lakshminarayanan, O. O'Sullivan, and et al. Gut microbiota composition correlates with diet and health in the elderly Nature 488 2012 178 184
13. T.A. Clayton, D. Baker, J.C. Lindon, J.R. Everett, and J.K. Nicholson Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism Proc. Natl. Acad. Sci. USA 106 2009 14728 14733
14. R.J. Colman, and D.T. Rubin Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis J. Crohn's Colitis 8 2014 1569 1581
15. L.A. David, C.F. Maurice, R.N. Carmody, D.B. Gootenberg, J.E. Button, B.E. Wolfe, A.V. Ling, A.S. Devlin, Y. Varma, M.A. Fischbach, and et al. Diet rapidly and reproducibly alters the human gut microbiome Nature 505 2014 559 563
16. M.C. de Goffau, K. Luopajärvi, M. Knip, J. Ilonen, T. Ruohtula, T. Härkönen, L. Orivuori, S. Hakala, G.W. Welling, H.J. Harmsen, and O. Vaarala Fecal microbiota composition differs between children with β-cell autoimmunity and those without Diabetes 62 2013 1238 1244
17. N. Dey, D.A. Soergel, S. Repo, and S.E. Brenner Association of gut microbiota with post-operative clinical course in Crohn's disease BMC Gastroenterol. 13 2013 131
18. B.J. Druker, F. Guilhot, S.G. O'Brien, I. Gathmann, H. Kantarjian, N. Gattermann, M.W.N. Deininger, R.T. Silver, J.M. Goldman, R.M. Stone, et al. IRIS Investigators Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia N. Engl. J. Med. 355 2006 2408 2417
19. P.B. Eckburg, E.M. Bik, C.N. Bernstein, E. Purdom, L. Dethlefsen, M. Sargent, S.R. Gill, K.E. Nelson, and D.A. Relman Diversity of the human intestinal microbial flora Science 308 2005 1635 1638
20. J. Elith, J.R. Leathwick, and T. Hastie A working guide to boosted regression trees J. Anim. Ecol. 77 2008 802 813
21. J.J. Farrell, L. Zhang, H. Zhou, D. Chia, D. Elashoff, D. Akin, B.J. Paster, K. Joshipura, and D.T.W. Wong Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer Gut 61 2012 582 588
22. R. Flores, J. Shi, G. Yu, B. Ma, J. Ravel, J.J. Goedert, and R. Sinha Collection media and delayed freezing effects on microbial composition of human stool Microbiome 3 2015 33
23. K. Forslund, F. Hildebrand, T. Nielsen, G. Falony, E. Le Chatelier, S. Sunagawa, E. Prifti, S. Vieira-Silva, V. Gudmundsdottir, H. Krogh Pedersen, et al. MetaHIT consortium Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota Nature 528 2015 262 266
24. D.N. Frank, A.L. St Amand, R.A. Feldman, E.C. Boedeker, N. Harpaz, and N.R. Pace Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases Proc. Natl. Acad. Sci. USA 104 2007 13780 13785
25. D. Gevers, S. Kugathasan, L.A. Denson, Y. Vázquez-Baeza, W. Van Treuren, B. Ren, E. Schwager, D. Knights, S.J. Song, M. Yassour, and et al. The treatment-naive microbiome in new-onset Crohn's disease Cell Host Microbe 15 2014 382 392
26. S.L. Greenbloom, A.H. Steinhart, and G.R. Greenberg Combination ciprofloxacin and metronidazole for active Crohn's disease Can. J. Gastroenterol. 12 1998 53 56
27. H.J. Haiser, D.B. Gootenberg, K. Chatman, G. Sirasani, E.P. Balskus, and P.J. Turnbaugh Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta Science 341 2013 295 298
28. M. Hamady, and R. Knight Microbial community profiling for human microbiome projects: Tools, techniques, and challenges Genome Res. 19 2009 1141 1152
29. M.A. Hamburg, and F.S. Collins The path to personalized medicine N. Engl. J. Med. 363 2010 301 304
30. F.B. Hu, E.B. Rimm, M.J. Stampfer, A. Ascherio, D. Spiegelman, and W.C. Willett Prospective study of major dietary patterns and risk of coronary heart disease in men Am. J. Clin. Nutr. 72 2000 912 921
31. N. Iida, A. Dzutsev, C.A. Stewart, L. Smith, N. Bouladoux, R.A. Weingarten, D.A. Molina, R. Salcedo, T. Back, S. Cramer, and et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment Science 342 2013 967 970
32. J.L. Jameson, and D.L. Longo Precision medicine - personalized, problematic, and promising N. Engl. J. Med. 372 2015 2229 2234
33. R. Kaddurah-Daouk, R.A. Baillie, H. Zhu, Z.-B. Zeng, M.M. Wiest, U.T. Nguyen, K. Wojnoonski, S.M. Watkins, M. Trupp, and R.M. Krauss Enteric microbiome metabolites correlate with response to simvastatin treatment PLoS ONE 6 2011 e25482
34. F.H. Karlsson, V. Tremaroli, I. Nookaew, G. Bergström, C.J. Behre, B. Fagerberg, J. Nielsen, and F. Bäckhed Gut metagenome in European women with normal, impaired and diabetic glucose control Nature 498 2013 99 103
35. K.M. Kemppainen, A.N. Ardissone, A.G. Davis-Richardson, J.R. Fagen, K.A. Gano, L.G. León-Novelo, K. Vehik, G. Casella, O. Simell, A.G. Ziegler, et al. TEDDY Study Group Early childhood gut microbiomes show strong geographic differences among subjects at high risk for type 1 diabetes Diabetes Care 38 2015 329 332
36. R.A. Koeth, Z. Wang, B.S. Levison, J.A. Buffa, E. Org, B.T. Sheehy, E.B. Britt, X. Fu, Y. Wu, L. Li, and et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis Nat. Med. 19 2013 576 585
37. P.T. Koleva, S.L. Bridgman, and A.L. Kozyrskyj The infant gut microbiome: evidence for obesity risk and dietary intervention Nutrients 7 2015 2237 2260
38. T. Korem, D. Zeevi, J. Suez, A. Weinberger, T. Avnit-Sagi, M. Pompan-Lotan, E. Matot, G. Jona, A. Harmelin, N. Cohen, and et al. Growth dynamics of gut microbiota in health and disease inferred from single metagenomic samples Science 349 2015 1101 1106
39. A.D. Kostic, D. Gevers, C.S. Pedamallu, M. Michaud, F. Duke, A.M. Earl, A.I. Ojesina, J. Jung, A.J. Bass, J. Tabernero, and et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma Genome Res. 22 2012 292 298
40. P. Kovatcheva-Datchary, A. Nilsson, R. Akrami, Y.S. Lee, F. De Vadder, T. Arora, A. Hallen, E. Martens, I. Björck, and F. Bäckhed Dietary Fiber-Induced Improvement in Glucose Metabolism Is Associated with Increased Abundance of Prevotella Cell Metab. 22 2015 971 982
41. E.L. Kwak, Y.-J. Bang, D.R. Camidge, A.T. Shaw, B. Solomon, R.G. Maki, S.-H.I. Ou, B.J. Dezube, P.A. Jänne, D.B. Costa, and et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer N. Engl. J. Med. 363 2010 1693 1703
42. E. Le Chatelier, T. Nielsen, J. Qin, E. Prifti, F. Hildebrand, G. Falony, M. Almeida, M. Arumugam, J.-M. Batto, S. Kennedy, et al. MetaHIT consortium Richness of human gut microbiome correlates with metabolic markers Nature 500 2013 541 546
43. J. Lindenbaum, D.G. Rund, V.P. Butler Jr., D. Tse-Eng, and J.R. Saha Inactivation of digoxin by the gut flora: reversal by antibiotic therapy N. Engl. J. Med. 305 1981 789 794
44. C. Manichanh, L. Rigottier-Gois, E. Bonnaud, K. Gloux, E. Pelletier, L. Frangeul, R. Nalin, C. Jarrin, P. Chardon, P. Marteau, and et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach Gut 55 2006 205 211
45. J.R. Marchesi, B.E. Dutilh, N. Hall, W.H.M. Peters, R. Roelofs, A. Boleij, and H. Tjalsma Towards the human colorectal cancer microbiome PLoS ONE 6 2011 e20447
46. K.H. Mikkelsen, M. Frost, M.I. Bahl, T.R. Licht, U.S. Jensen, J. Rosenberg, O. Pedersen, T. Hansen, J.F. Rehfeld, J.J. Holst, and et al. Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism PLoS ONE 10 2015 e0142352
47. B.D. Muegge, J. Kuczynski, D. Knights, J.C. Clemente, A. González, L. Fontana, B. Henrissat, R. Knight, and J.I. Gordon Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans Science 332 2011 970 974
48. M. Ng, T. Fleming, M. Robinson, B. Thomson, N. Graetz, C. Margono, E.C. Mullany, S. Biryukov, C. Abbafati, S.F. Abera, and et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013 Lancet 384 2014 766 781
49. J.K. Nicholson, E. Holmes, and I.D. Wilson Gut microorganisms, mammalian metabolism and personalized health care Nat. Rev. Microbiol. 3 2005 431 438
50. J.M. Norman, S.A. Handley, M.T. Baldridge, L. Droit, C.Y. Liu, B.C. Keller, A. Kambal, C.L. Monaco, G. Zhao, P. Fleshner, and et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease Cell 160 2015 447 460
51. H. Okuda, K. Ogura, A. Kato, H. Takubo, and T. Watabe A possible mechanism of eighteen patient deaths caused by interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs J. Pharmacol. Exp. Ther. 287 1998 791 799
52. J. Qin, Y. Li, Z. Cai, S. Li, J. Zhu, F. Zhang, S. Liang, W. Zhang, Y. Guan, D. Shen, and et al. A metagenome-wide association study of gut microbiota in type 2 diabetes Nature 490 2012 55 60
53. T.R. Rebbeck, T. Friebel, H.T. Lynch, S.L. Neuhausen, L. van 't Veer, J.E. Garber, G.R. Evans, S.A. Narod, C. Isaacs, E. Matloff, and et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group J. Clin. Oncol. 22 2004 1055 1062
54. V.K. Ridaura, J.J. Faith, F.E. Rey, J. Cheng, A.E. Duncan, A.L. Kau, N.W. Griffin, V. Lombard, B. Henrissat, J.R. Bain, and et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice Science 341 2013 1241214
55. S. Rohrmann, K. Overvad, H.B. Bueno-de-Mesquita, M.U. Jakobsen, R. Egeberg, A. Tjønneland, L. Nailler, M.-C. Boutron-Ruault, F. Clavel-Chapelon, V. Krogh, and et al. Meat consumption and mortality - results from the European Prospective Investigation into Cancer and Nutrition BMC Med. 11 2013 63
56. J.U. Scher, A. Sczesnak, R.S. Longman, N. Segata, C. Ubeda, C. Bielski, T. Rostron, V. Cerundolo, E.G. Pamer, S.B. Abramson, and et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis eLife 2 2013 e01202
57. T. Simon, C. Verstuyft, M. Mary-Krause, L. Quteineh, E. Drouet, N. Méneveau, P.G. Steg, J. Ferrières, N. Danchin, and L. Becquemont Genetic determinants of response to clopidogrel and cardiovascular events N. Engl. J. Med. 360 2009 363 375
58. R. Sinha, A.J. Cross, B.I. Graubard, M.F. Leitzmann, and A. Schatzkin Meat intake and mortality: a prospective study of over half a million people Arch. Intern. Med. 169 2009 562 571
59. A. Sivan, L. Corrales, N. Hubert, J.B. Williams, K. Aquino-Michaels, Z.M. Earley, F.W. Benyamin, Y.M. Lei, B. Jabri, M.-L. Alegre, and et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy Science 350 2015 1084 1089
60. M.A. Skinner, J.A. Moley, W.G. Dilley, K. Owzar, M.K. Debenedetti, and S.A. Wells Jr. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A N. Engl. J. Med. 353 2005 1105 1113
61. I. Sobhani, J. Tap, F. Roudot-Thoraval, J.P. Roperch, S. Letulle, P. Langella, G. Corthier, J. Tran Van Nhieu, and J.P. Furet Microbial dysbiosis in colorectal cancer (CRC) patients PLoS ONE 6 2011 e16393
62. H. Sokol, B. Pigneur, L. Watterlot, O. Lakhdari, L.G. Bermúdez-Humarán, J.-J. Gratadoux, S. Blugeon, C. Bridonneau, J.-P. Furet, G. Corthier, and et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients Proc. Natl. Acad. Sci. USA 105 2008 16731 16736
63. L.M. Sollid Molecular basis of celiac disease Annu. Rev. Immunol. 18 2000 53 81
64. A.H. Steinhart, B.G. Feagan, C.J. Wong, M. Vandervoort, S. Mikolainis, K. Croitoru, E. Seidman, D.J. Leddin, A. Bitton, E. Drouin, and et al. Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial Gastroenterology 123 2002 33 40
65. J. Suez, T. Korem, D. Zeevi, G. Zilberman-Schapira, C.A. Thaiss, O. Maza, D. Israeli, N. Zmora, S. Gilad, A. Weinberger, and et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota Nature 514 2014 181 186
66. V. Taneja Arthritis susceptibility and the gut microbiome FEBS Lett. 588 2014 4244 4249
67. W.H.W. Tang, Z. Wang, B.S. Levison, R.A. Koeth, E.B. Britt, X. Fu, Y. Wu, and S.L. Hazen Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk N. Engl. J. Med. 368 2013 1575 1584
68. S.R. Targan, C.J. Landers, H. Yang, M.J. Lodes, Y. Cong, K.A. Papadakis, E. Vasiliauskas, C.O. Elson, and R.M. Hershberg Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease Gastroenterology 128 2005 2020 2028
69. C.A. Thaiss, D. Zeevi, M. Levy, G. Zilberman-Schapira, J. Suez, A.C. Tengeler, L. Abramson, M.N. Katz, T. Korem, N. Zmora, and et al. Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis Cell 159 2014 514 529
70. P.J. Torres, E.M. Fletcher, S.M. Gibbons, M. Bouvet, K.S. Doran, and S.T. Kelley Characterization of the salivary microbiome in patients with pancreatic cancer PeerJ 3 2015 e1373
71. P.J. Turnbaugh, R.E. Ley, M.A. Mahowald, V. Magrini, E.R. Mardis, and J.I. Gordon An obesity-associated gut microbiome with increased capacity for energy harvest Nature 444 2006 1027 1031
72. P.J. Turnbaugh, M. Hamady, T. Yatsunenko, B.L. Cantarel, A. Duncan, R.E. Ley, M.L. Sogin, W.J. Jones, B.A. Roe, J.P. Affourtit, and et al. A core gut microbiome in obese and lean twins Nature 457 2009 480 484
73. A.D. Tyler, N. Knox, B. Kabakchiev, R. Milgrom, R. Kirsch, Z. Cohen, R.S. McLeod, D.S. Guttman, D.O. Krause, and M.S. Silverberg Characterization of the gut-associated microbiome in inflammatory pouch complications following ileal pouch-anal anastomosis PLoS ONE 8 2013 e66934
74. M. Vétizou, J.M. Pitt, R. Daillère, P. Lepage, N. Waldschmitt, C. Flament, S. Rusakiewicz, B. Routy, M.P. Roberti, C.P.M. Duong, and et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota Science 350 2015 1079 1084
75. M. Vijay-Kumar, J.D. Aitken, F.A. Carvalho, T.C. Cullender, S. Mwangi, S. Srinivasan, S.V. Sitaraman, R. Knight, R.E. Ley, and A.T. Gewirtz Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5 Science 328 2010 228 231
76. P. Wacklin, K. Kaukinen, E. Tuovinen, P. Collin, K. Lindfors, J. Partanen, M. Mäki, and J. Mättö The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease Inflamm. Bowel Dis. 19 2013 934 941
77. B.D. Wallace, H. Wang, K.T. Lane, J.E. Scott, J. Orans, J.S. Koo, M. Venkatesh, C. Jobin, L.-A. Yeh, S. Mani, and M.R. Redinbo Alleviating cancer drug toxicity by inhibiting a bacterial enzyme Science 330 2010 831 835
78. J. Wehkamp, N.H. Salzman, E. Porter, S. Nuding, M. Weichenthal, R.E. Petras, B. Shen, E. Schaeffeler, M. Schwab, R. Linzmeier, and et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease Proc. Natl. Acad. Sci. USA 102 2005 18129 18134
79. B. Willing, J. Halfvarson, J. Dicksved, M. Rosenquist, G. Järnerot, L. Engstrand, C. Tysk, and J.K. Jansson Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease Inflamm. Bowel Dis. 15 2009 653 660
80. B.P. Willing, J. Dicksved, J. Halfvarson, A.F. Andersson, M. Lucio, Z. Zheng, G. Järnerot, C. Tysk, J.K. Jansson, and L. Engstrand A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes Gastroenterology 139 2010 1844 1854.e1
81. S. Winawer, R. Fletcher, D. Rex, J. Bond, R. Burt, J. Ferrucci, T. Ganiats, T. Levin, S. Woolf, D. Johnson, et al. Gastrointestinal Consortium Panel Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence Gastroenterology 124 2003 544 560
82. T. Wizemann, A.C. Berger Roundtable on Translating Genomic-Based Research for Health Pharmacogenomic Testing to Guide Warfarin Dosing The Value of Genetic and Genomic Technologies 2010 National Academies Press
83. G.D. Wu, J. Chen, C. Hoffmann, K. Bittinger, Y.-Y. Chen, S.A. Keilbaugh, M. Bewtra, D. Knights, W.A. Walters, R. Knight, and et al. Linking long-term dietary patterns with gut microbial enterotypes Science 334 2011 105 108
84. A.W. Yan, D.E. Fouts, J. Brandl, P. Stärkel, M. Torralba, E. Schott, H. Tsukamoto, K.E. Nelson, D.A. Brenner, and B. Schnabl Enteric dysbiosis associated with a mouse model of alcoholic liver disease Hepatology 53 2011 96 105
85. J.P. Zackular, M.A.M. Rogers, M.T. Ruffin 4th, and P.D. Schloss The human gut microbiome as a screening tool for colorectal cancer Cancer Prev. Res. (Phila.) 7 2014 1112 1121
86. D. Zeevi, T. Korem, N. Zmora, D. Israeli, D. Rothschild, A. Weinberger, O. Ben-Yacov, D. Lador, T. Avnit-Sagi, M. Lotan-Pompan, and et al. Personalized Nutrition by Prediction of Glycemic Responses Cell 163 2015 1079 1094
87. X. Zhang, D. Shen, Z. Fang, Z. Jie, X. Qiu, C. Zhang, Y. Chen, and L. Ji Human gut microbiota changes reveal the progression of glucose intolerance PLoS ONE 8 2013 e71108